CORRECTION - CFN Media Examines Medical Marijuana, Inc.''s Investment in Cannabinoid Patent Licenses
(firmenpresse) - SEATTLE, WA -- (Marketwired) -- 07/07/16 -- In the news release issued Wednesday, July 6, 2016 by CFN Media Group, we are advised by the company that only one of the two patent licenses held by Medical Marijuana, Inc.''s (OTC PINK: MJNA) portfolio company Kannalife™ Sciences is exclusive, rather than both licenses being exclusive as originally issued. Complete corrected text follows.
SEATTLE, WA -- Jul 6, 2016 -- CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and interview discussing the potential impact of two patent licenses for cannabinoid (CBD) commercialization on Medical Marijuana, Inc. (OTC PINK: MJNA).
Medical Marijuana was the first public company in the legal cannabis industry and is involved in a wide array of hemp- and cannabis-based business ventures. The focus of today''s release is MJNA''s portfolio company which holds one exclusive license to the National Institutes of Health''s so-called ''507'' patent on cannabinoids as antioxidants and neuroprotectants to treat Hepatic Encephalopathy (HE), and a second license to treat Chronic Traumatic Encephalopathy (CTE).
To read the full article on CannabisFN.com, click the following link or copy and paste the URL into your browser:
Learn how to become a CFN Media featured company, brand or entrepreneur:
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone:
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone:
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.''s portfolio and investment companies, visit .
The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.''s video statement, . Shareholders are also encouraged to visit the for discounted products.
Frank Lane
206-369-7050
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 07.07.2016 - 17:56 Uhr
Sprache: Deutsch
News-ID 1445819
Anzahl Zeichen: 2433
contact information:
Contact person:
Town:
SEATTLE, WA
Phone:
Kategorie:
Investment Services & Trading
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 193 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"CORRECTION - CFN Media Examines Medical Marijuana, Inc.''s Investment in Cannabinoid Patent Licenses
"
steht unter der journalistisch-redaktionellen Verantwortung von
CFN Media Group (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
